Gilead Sciences’ drug remdesivir will soon be given to pediatric patients with moderate to severe cases of COVID-19 as part of a clinical trial.
Source: NY Post click here for more…
Gilead Sciences’ drug remdesivir will soon be given to pediatric patients with moderate to severe cases of COVID-19 as part of a clinical trial.
Source: NY Post click here for more…